Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Feasibility Study of the Vessel Restoration System (VRS) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Popliteal Artery (PA) after Sub-optimal percutaneous transluminal angioplasty (PTA) or Atherectomy: REACTIVATE I
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Vessel Restoration System (VRS) | Combination Product | The VRS includes the following components:
|
| Measure | Description | Time Frame |
|---|---|---|
| An acute reduction in arterial dissections | Reduction in arterial dissection(s) of at least one grade. | 12 months |
| Primary Patency as assessed by Doppler Ultrasound (DUS) and freedom from CD-TLR at 1 Year | Primary Patency as assessed by Doppler Ultrasound (DUS) | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Technical Success | Technical success is defined by successful delivery of the VRS | 12 months |
| Procedural Success | Procedural Success is defined as an acute reduction in arterial dissection(s) |
| Measure | Description | Time Frame |
|---|---|---|
| Major Adverse Limb Events | 36 months | |
| Reintervention for treatment of thrombosis of the target vessel or embolization to its distal Vasculature | 36 months | |
| Major Vascular Complications |
Inclusion Criteria:
Subjects for this study must meet all of the following general eligibility criteria
AND the answer must be "YES" to all general inclusion criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Flinders Medical Center | Adelaide | South Australia | Australia | |||
| The Alfred Hospital |
Not sharing IPD
Not provided
Not provided
Not provided
Not provided
Not provided
This study is a prospective, nonrandomized, multicenter, open-label feasibility study of the VRS for the treatment of atherosclerotic de novo or restenotic lesions in the SFA and/or PA after sub-optimal PTA or atherectomy angiographic outcomes.
Not provided
Not provided
Not provided
Not provided
| 12 months |
| Clinical Success | Clinical success is defined as freedom from CD-TLR | 36 months |
| Safety Measure | Frequency of MAEs | 72 months |
| Hemodynamic Improvement | Rate of hemodynamic improvement ABI | 36 months |
| Rutherford Classification | As assessed by changes in Rutherford Class | 36 months |
| Quality of Life Measure | Quality of life (QOL) assessment by EQ-5D | 72 months |
| 36 months |
| Melbourne |
| Victoria |
| Australia |